Detection of Slipped-DNAs at the Trinucleotide Repeats of the Myotonic Dystrophy Type I Disease Locus in Patient Tissues | PLOS Genetics
![SMRT Sequencing Detects Clinically Significant Repeat Changes In Triplet Expansion Disorders - PacBio SMRT Sequencing Detects Clinically Significant Repeat Changes In Triplet Expansion Disorders - PacBio](https://www.pacb.com/wp-content/uploads/Screenshot-2021-04-21-at-3.21.27-PM-300x206.png)
SMRT Sequencing Detects Clinically Significant Repeat Changes In Triplet Expansion Disorders - PacBio
![PDF] Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. | Semantic Scholar PDF] Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/963ac630b1adba5d4b8cd493f3759715af1e5297/5-Table1-1.png)
PDF] Myotonic dystrophy: disease repeat range, penetrance, age of onset, and relationship between repeat size and phenotypes. | Semantic Scholar
![Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors | Biochemistry Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors | Biochemistry](https://pubs.acs.org/cms/10.1021/acs.biochem.0c00472/asset/images/large/bi0c00472_0003.jpeg)
Expanded DNA and RNA Trinucleotide Repeats in Myotonic Dystrophy Type 1 Select Their Own Multitarget, Sequence-Selective Inhibitors | Biochemistry
![Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations | European Journal of Human Genetics Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations | European Journal of Human Genetics](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41431-020-0601-4/MediaObjects/41431_2020_601_Fig1_HTML.png)
Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations | European Journal of Human Genetics
![What is myotonic dystrophy? Myotonic dystrophy is part of a group of inherited disorders called muscular dystrophies. It is the most common form of muscular. - ppt download What is myotonic dystrophy? Myotonic dystrophy is part of a group of inherited disorders called muscular dystrophies. It is the most common form of muscular. - ppt download](https://images.slideplayer.com/24/6941780/slides/slide_5.jpg)
What is myotonic dystrophy? Myotonic dystrophy is part of a group of inherited disorders called muscular dystrophies. It is the most common form of muscular. - ppt download
![Genes | Free Full-Text | Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism Genes | Free Full-Text | Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism](https://www.mdpi.com/genes/genes-04-00375/article_deploy/html/images/genes-04-00375-g001.png)
Genes | Free Full-Text | Abnormal Base Excision Repair at Trinucleotide Repeats Associated with Diseases: A Tissue-Selective Mechanism
![Trinucleotide repeat disorders: An interesting interface between psychiatry and medicine | BJPsych Advances | Cambridge Core Trinucleotide repeat disorders: An interesting interface between psychiatry and medicine | BJPsych Advances | Cambridge Core](https://static.cambridge.org/binary/version/id/urn:cambridge.org:id:binary:20180515042413264-0158:S2056467800003042:S2056467800003042_tab1.gif?pub-status=live)
Trinucleotide repeat disorders: An interesting interface between psychiatry and medicine | BJPsych Advances | Cambridge Core
![Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy](https://www.cell.com/cms/attachment/1ab7b752-b62a-4f51-888b-dc27651f833d/fx1_lrg.jpg)
Application of CRISPR-Cas9-Mediated Genome Editing for the Treatment of Myotonic Dystrophy Type 1: Molecular Therapy
![Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach: Molecular Therapy - Methods & Clinical Development Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach: Molecular Therapy - Methods & Clinical Development](https://www.cell.com/cms/attachment/1ce8baf1-ee7b-4f6a-a306-2b938c4ccefc/fx1_lrg.jpg)
Unexpected Mutations by CRISPR-Cas9 CTG Repeat Excision in Myotonic Dystrophy and Use of CRISPR Interference as an Alternative Approach: Molecular Therapy - Methods & Clinical Development
![Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCR - ScienceDirect Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCR - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1769721214002225-gr1.jpg)
Molecular genetic analysis of trinucleotide repeat disorders (TRDs) in Indian population and application of repeat primed PCR - ScienceDirect
![IJMS | Free Full-Text | Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing IJMS | Free Full-Text | Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing](https://www.mdpi.com/ijms/ijms-23-04622/article_deploy/html/images/ijms-23-04622-g001.png)